{"pub": "wsj", "url": "https://marketwatch.com/story/cvs-walgreens-rite-aid-pull-zantac-from-shelves-over-carcinogen-worries-2019-09-30?mod=rsswn", "downloaded_at": "2019-10-01 04:27:53.778676+00:00", "title": "CVS, Walgreens, Rite Aid pull Zantac from shelves over carcinogen worries", "language": "en", "text": "Three of the nation\u2019s largest pharmacies will stop selling the heartburn medication Zantac and similar generic products following a warning by the Food and Drug Administration that the drug may contain low levels of a potentially cancer-causing substance.\n\nCVS Health Corp. CVS, +1.59% suspended sales of Zantac and products containing ranitidine on Saturday. \u201cThis action is being taken out of an abundance of caution,\u201d the company said in a statement. On Monday, Walgreens WBA, +1.65% and Rite Aid Corp. RAD, -4.53% said they, too, were removing the drugs from their shelves.\n\nEarlier this month, the FDA said some ranitidine medicines, including Zantac, \u201ccontain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is classified as a probable human carcinogen.\u201d\n\nThe FDA said it is still investigating whether the NDMA levels pose a risk to patients. \u201cAlthough NDMA may cause harm in large amounts, the levels the FDA is finding in ranitidine from preliminary tests barely exceed amounts you might expect to find in common foods,\u201d the agency said in a statement.\n\nThe FDA said it was not recalling the medication nor calling for patients to stop using products with ranitidine, but said that those with concerns should talk to their doctor or consider similar over-the-counter medications that do not contain ranitidine.\n\nAll three drug-store companies said customers could return their ranitidine medications for a refund.\n\nZantac is made by Sanofi SA SNY, +0.15% .", "description": "Three of the nation\u2019s largest pharmacies will stop selling the heartburn medication Zantac and similar generic products following a warning by the Food and...", "authors": ["Mike Murphy"], "top_image": "http://s.marketwatch.com/public/resources/MWimages/MW-HS359_zantac_ZG_20190930213638.jpg", "published_at": "2019-09-30"}